Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $35.6700 (0.99%) ($35.0500 - $35.9900) on Tue. Apr. 16, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.44% (three month average) | RSI | 54 | Latest Price | $35.6700(0.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.7% a day on average for past five trading days. | Weekly Trend | ATRA declines -3.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -1.72% in a week (0% probabilities). UUP(-14%) VXX(-13%) TLT(-13%) VIXM(-10%) UNG(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.72% (StdDev 3.44%) | Hourly BBV | 0 () | Intraday Trend | -0.1% | | | |
|
1 - 5 Day Possible Target | $27.75(-22.2%) | Resistance Level | $38.06 | 5 Day Moving Average | $36.07(-1.11%) | 10 Day Moving Average | $37.62(-5.18%) | 20 Day Moving Average | $38.06(-6.28%) | To recent high | -14.5% | To recent low | 3.5% | Market Cap | $2.651b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |